These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 22973029)

  • 1. Suppression of viral RNA binding and the assembly of infectious hepatitis C virus particles in vitro by cyclophilin inhibitors.
    Nag A; Robotham JM; Tang H
    J Virol; 2012 Dec; 86(23):12616-24. PubMed ID: 22973029
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A major determinant of cyclophilin dependence and cyclosporine susceptibility of hepatitis C virus identified by a genetic approach.
    Yang F; Robotham JM; Grise H; Frausto S; Madan V; Zayas M; Bartenschlager R; Robinson M; Greenstein AE; Nag A; Logan TM; Bienkiewicz E; Tang H
    PLoS Pathog; 2010 Sep; 6(9):e1001118. PubMed ID: 20886100
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A conserved tandem cyclophilin-binding site in hepatitis C virus nonstructural protein 5A regulates Alisporivir susceptibility.
    Grisé H; Frausto S; Logan T; Tang H
    J Virol; 2012 May; 86(9):4811-22. PubMed ID: 22345441
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HCV resistance to cyclosporin A does not correlate with a resistance of the NS5A-cyclophilin A interaction to cyclophilin inhibitors.
    Chatterji U; Lim P; Bobardt MD; Wieland S; Cordek DG; Vuagniaux G; Chisari F; Cameron CE; Targett-Adams P; Parkinson T; Gallay PA
    J Hepatol; 2010 Jul; 53(1):50-6. PubMed ID: 20451281
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The cyclophilin inhibitor SCY-635 disrupts hepatitis C virus NS5A-cyclophilin A complexes.
    Hopkins S; Bobardt M; Chatterji U; Garcia-Rivera JA; Lim P; Gallay PA
    Antimicrob Agents Chemother; 2012 Jul; 56(7):3888-97. PubMed ID: 22585215
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The use of AlphaLISA technology to detect interaction between hepatitis C virus-encoded NS5A and cyclophilin A.
    Waller H; Chatterji U; Gallay P; Parkinson T; Targett-Adams P
    J Virol Methods; 2010 May; 165(2):202-10. PubMed ID: 20132841
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of HCV replication by cyclophilin antagonists is linked to replication fitness and occurs by inhibition of membranous web formation.
    Madan V; Paul D; Lohmann V; Bartenschlager R
    Gastroenterology; 2014 May; 146(5):1361-72.e1-9. PubMed ID: 24486951
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclophilin A is an essential cofactor for hepatitis C virus infection and the principal mediator of cyclosporine resistance in vitro.
    Yang F; Robotham JM; Nelson HB; Irsigler A; Kenworthy R; Tang H
    J Virol; 2008 Jun; 82(11):5269-78. PubMed ID: 18385230
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The isomerase active site of cyclophilin A is critical for hepatitis C virus replication.
    Chatterji U; Bobardt M; Selvarajah S; Yang F; Tang H; Sakamoto N; Vuagniaux G; Parkinson T; Gallay P
    J Biol Chem; 2009 Jun; 284(25):16998-17005. PubMed ID: 19380579
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Critical role of cyclophilin A and its prolyl-peptidyl isomerase activity in the structure and function of the hepatitis C virus replication complex.
    Liu Z; Yang F; Robotham JM; Tang H
    J Virol; 2009 Jul; 83(13):6554-65. PubMed ID: 19386705
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cyclophilin A interacts with domain II of hepatitis C virus NS5A and stimulates RNA binding in an isomerase-dependent manner.
    Foster TL; Gallay P; Stonehouse NJ; Harris M
    J Virol; 2011 Jul; 85(14):7460-4. PubMed ID: 21593166
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ISGylation of Hepatitis C Virus NS5A Protein Promotes Viral RNA Replication via Recruitment of Cyclophilin A.
    Abe T; Minami N; Bawono RG; Matsui C; Deng L; Fukuhara T; Matsuura Y; Shoji I
    J Virol; 2020 Sep; 94(20):. PubMed ID: 32727878
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The C terminus of NS5A domain II is a key determinant of hepatitis C virus genome replication, but is not required for virion assembly and release.
    Ross-Thriepland D; Amako Y; Harris M
    J Gen Virol; 2013 May; 94(Pt 5):1009-1018. PubMed ID: 23324467
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Essential role of cyclophilin A for hepatitis C virus replication and virus production and possible link to polyprotein cleavage kinetics.
    Kaul A; Stauffer S; Berger C; Pertel T; Schmitt J; Kallis S; Zayas M; Lohmann V; Luban J; Bartenschlager R
    PLoS Pathog; 2009 Aug; 5(8):e1000546. PubMed ID: 19680534
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PACSIN2 Interacts with Nonstructural Protein 5A and Regulates Hepatitis C Virus Assembly.
    Nguyen LP; Tran SC; Suetsugu S; Lim YS; Hwang SB
    J Virol; 2020 Feb; 94(5):. PubMed ID: 31801866
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of cellular and viral factors related to anti-hepatitis C virus activity of cyclophilin inhibitor.
    Goto K; Watashi K; Inoue D; Hijikata M; Shimotohno K
    Cancer Sci; 2009 Oct; 100(10):1943-50. PubMed ID: 19659609
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiple mutations in hepatitis C virus NS5A domain II are required to confer a significant level of resistance to alisporivir.
    Garcia-Rivera JA; Bobardt M; Chatterji U; Hopkins S; Gregory MA; Wilkinson B; Lin K; Gallay PA
    Antimicrob Agents Chemother; 2012 Oct; 56(10):5113-21. PubMed ID: 22802259
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclosporine inhibits a direct interaction between cyclophilins and hepatitis C NS5A.
    Fernandes F; Ansari IU; Striker R
    PLoS One; 2010 Mar; 5(3):e9815. PubMed ID: 20352119
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytosolic phospholipase A2 gamma is involved in hepatitis C virus replication and assembly.
    Xu S; Pei R; Guo M; Han Q; Lai J; Wang Y; Wu C; Zhou Y; Lu M; Chen X
    J Virol; 2012 Dec; 86(23):13025-37. PubMed ID: 23015700
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclophilin inhibitors for the treatment of HCV infection.
    Fischer G; Gallay P; Hopkins S
    Curr Opin Investig Drugs; 2010 Aug; 11(8):911-8. PubMed ID: 20721833
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.